logo
logo
Sign in

Using Bremelanotide Intranasal Spray To Treat HSDD

avatar
Harborcompounding Pharmacy
Using Bremelanotide Intranasal Spray To Treat HSDD

The food and drug administration in the United States approved Bremelanotide to treat women’s sexual health problems like low sexual desire in women before menopause. So bremelanotide is used to treat generalized hypoactive sexual desire disorder or acquired hypoactive sexual desire disorder. Bremelanotide is sold under the name Vyleesi. Hypoactive sexual desire disorder (HSDD) is a condition that is marked not only by low sexual desire but also by distress, relationship difficulties, mental health conditions, etc.

collect
0
avatar
Harborcompounding Pharmacy
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more